Skip to content
If you missed the recent Special COVID-19 Webex, Dialyzing Patients in Skilled Nursing Homes During COVID-19, the recording is now available online. Speakers included Alice Hellebrand, Chief Nursing Officer of Dialyzer Direct; and LaKeisha Jones, Vice President of Clinical Services of Concerto Renal Services. They discussed the new structure for dialysis patients in nursing homes
San Antonio, Texas, 4e Brands North America is voluntarily recalling ten (10) bottle sizes of Hand Sanitizers to the consumer level. The products are being recalled due to the potential presence of methanol (wood alcohol). Risk Statement: Substantial methanol exposure could result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, permanent damage to the
The U.S. Food and Drug Administration (FDA) recommends that health care providers continue to use serological tests intended to detect antibodies to SARS-CoV-2 to help identify people who may have been exposed to the SARS-CoV-2 virus or have recovered from the COVID-19 infection. Health care providers should also be aware of the limitations of these
CMS, State, and local communities, continue to promote safe and responsible pain management; however, Opioid Use Disorder (OUD), overdoses, and deaths continue to be a growing concern. The following links and tools can help you better understand the current crisis and assist your patients with effective pain management if needed. Pain Management Zone ToolCMS Roadmap:
A COVID-19 module has been added to the 5 Diamond Patient Safety Program website and is available for any dialysis provider to access. The module was developed in partnership with the American Society of Nephrology (ASN). Objectives for the module include: Discuss COVID-19, including what it is and how it spreads. Identify symptoms of COVID-19. Describe
AUDIENCE: Health Professional, Pharmacy, Patient ISSUE: FDA is warning health care providers that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral activity of remdesivir. The agency is not aware of instances of this reduced activity occurring in the clinical setting but, is continuing to evaluate all
Amneal Pharmaceuticals LLC Bridgewater, New Jersey (Amneal), is voluntarily recalling all lots of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg, within expiry to the Retail Level. Amneal was notified by the U.S. FDA that the Agency’s testing of seven lots of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750
The U.S. Food and Drug Administration (FDA) reminds reprocessing staff in health care facilities to use the correct decontamination cycle associated with certain models of the Advanced Sterilization Products (ASP) STERRAD Sterilization Systems and to only decontaminate compatible N95 or N95-equivalent respirators for reuse during the COVID-19 pandemic. ASP STERRAD Sterilization Systems use vaporized hydrogen
Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The products are being recalled because our testing has found these lots to be superpotent. The product may have up to 115.0% of the labeled amount of Liothyronine (T3). Risk
The U.S. Food and Drug Administration (FDA) recommends that healthcare providers continue to use serological tests intended to detect antibodies to SARS-CoV-2 to help identify people who may have been exposed to the SARS-CoV-2 virus or have recovered from the COVID-19 infection. Healthcare providers should also be aware of the limitations of these tests and